Top Cities for Zika Virus Clinical Trials
Zika Virus clinical trials are recruiting across 9 cities. Here are the cities with the most active studies:
About Zika Virus
Zika virus is a mosquito-borne flavivirus that can cause birth defects (microcephaly) when contracted during pregnancy. Most infections are mild or asymptomatic in adults. Research focuses on vaccine development and understanding the link to neurological complications.
Clinical trials are advancing new treatments for zika virus. Currently, 1 studies are recruiting a combined 800 participants across the United States. Research is being conducted by 1 organizations including Cerus Corporation.
2026 Zika Virus Research Landscape
As of March 2026, the zika virus clinical trial landscape includes 1 actively recruiting studies across 9 cities in the United States. These studies are collectively seeking 800 participants, with an average enrollment target of 800 per study.
Research is being led by 1 organization, including Cerus Corporation.
Geographically, zika virus trials are most concentrated in Atlanta, Georgia (2 trials); Phoenix, Arizona (1 trial); New Haven, Connecticut (1 trial); Jacksonville, Florida (1 trial); Las Vegas, Nevada (1 trial) and 4 other cities.
Featured Zika Virus Studies
Highlighted recruiting studies for zika virus, selected by enrollment size and research scope.
INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections
Stage A: To evaluate the safety and efficacy of red blood cells (RBCs) prepared with the INTERCEPT Blood System for Red Blood Cells Pathogen Reduction Treatment (PRT) in comparison to conventional RBCs in patients who require RBC transfusion support. Stage B: To provide early access to the INTERCEPT pathogen reduction system for RBC in regions where a substantial proportion of the population has ...
Frequently Asked Questions About Zika Virus Clinical Trials
Are there zika virus clinical trials near me?
Yes, there are 1 zika virus clinical trials currently recruiting across 9+ cities in the United States, including Atlanta, Georgia; Phoenix, Arizona; New Haven, Connecticut. Browse the studies above to find one at a location convenient for you.
How do I join a zika virus clinical trial?
To join a zika virus clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are zika virus clinical trials free?
Yes, participation in zika virus clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of zika virus treatments are being studied?
Current zika virus clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in zika virus clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov